Ex vivo drug screening defines novel drug sensitivity...

Blood Advances 2020 / 06 Vol. 4; Iss. 12

Ex vivo drug screening defines novel drug sensitivity patterns for informing personalized therapy in myeloid neoplasms

Spinner, Michael A., Aleshin, Alexey, Santaguida, Marianne T., Schaffert, Steven A., Zehnder, James L., Patterson, A. Scott, Gekas, Christos, Heiser, Diane, Greenberg, Peter L.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
4
Journal:
Blood Advances
DOI:
10.1182/bloodadvances.2020001934
Date:
June, 2020
File:
PDF, 1.30 MB
2020
Conversion to is in progress
Conversion to is failed